Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a heterogenous disease with historically relative poor outcomes. However, new treatment strategies seem to be improving the prognosis for patients. Although no universally accepted standard of care exists, options for patients with newly diagnosed MCL include intensive and nonintensive strategies. Generally, intensive strategies produce more durable remissions and are selected for younger patients, whereas nonintensive strategies are most appropriate for older patients or patients with comorbidities. However, new options are closing the treatment gap between intensive and nonintensive strategies. Treatment options are also increasing for patients with relapsed/refractory MCL and include agents targeting the microenvironment and the B-cell receptor signaling pathway.

Target Audience

This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Summarize the current and emerging treatment options for MCL in the frontline setting
  • Discuss the evidence from clinical trials supporting the use of maintenance therapy in patients with MCL
  • Review the mechanism action, safety, and efficacy of targeted therapies in the management of R/R MCL
Additional information
Supporters: 

No commercial support was received for this article.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician
Course opens: 
09/05/2014
Course expires: 
09/05/2015
Cost:
$0.00

Saurabh Rajguru, MD
Department of Medicine, Division of Hematology/Oncology,
University of Wisconsin School of Medicine and Public Health, and the
UW Carbone Cancer Center, University of Wisconsin
Madison, Wisconsin

Brad S. Kahl, MD
Department of Medicine, Division of Hematology/Oncology,
University of Wisconsin School of Medicine and Public Health, and the
UW Carbone Cancer Center, University of Wisconsin
Madison, Wisconsin

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician

Accreditation Period

Course opens: 
09/05/2014
Course expires: 
09/05/2015

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for article and certificate viewing/printing